(Q50491235)

14 March 2018

title

Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease. (English)

1 reference

14 March 2018

inflammatory bowel diseases

main subject

0 references

author name string

Laura Sempere

1

1 reference

14 March 2018

Isabel Almenta

2

1 reference

14 March 2018

Julio Barrenengoa

3

1 reference

14 March 2018

Ana Gutiérrez

4

1 reference

14 March 2018

Cesar O Villanueva

5

1 reference

14 March 2018

Enrique de-Madaria

6

1 reference

14 March 2018

Vicente García

7

1 reference

14 March 2018

José Sánchez-Payá

8

1 reference

14 March 2018

language of work or name

English

0 references

publication date

9 May 2013

1 reference

14 March 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

14 March 2018

volume

31

1 reference

14 March 2018

issue

30

1 reference

14 March 2018

page(s)

3065-3071

1 reference

14 March 2018

Hepatitis B: global importance and need for control

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

European evidence-based Consensus on the management of ulcerative colitis: Special situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Vaccines and vaccination programs--special emphasis in malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Meta-analysis: the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Glucocorticoids in T cell development and function*.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Effects of long-term low-dose corticosteroid therapy on humoral immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Influenza vaccination in patients with rheumatic diseases. Safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

Classification of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Specificities of albumin receptors and albumin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.04.059

1 reference

14 March 2018

1 reference

14 March 2018